MigR1-AE9a Citations (9)

Originally described in: A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y, Chen IM, Chen Z, Rowley JD, Willman CL, Zhang DE Nat Med. 2006 Aug . 12(8):945-9. PubMed Journal

---

Articles Citing MigR1-AE9a

Articles
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia. Glaser SP, Lee EF, Trounson E, Bouillet P, Wei A, Fairlie WD, Izon DJ, Zuber J, Rappaport AR, Herold MJ, Alexander WS, Lowe SW, Robb L, Strasser A. Genes Dev. 2012 Jan 15;26(2):120-5. doi: 10.1101/gad.182980.111. PubMed
An experimentally validated network of nine haematopoietic transcription factors reveals mechanisms of cell state stability. Schutte J, Wang H, Antoniou S, Jarratt A, Wilson NK, Riepsaame J, Calero-Nieto FJ, Moignard V, Basilico S, Kinston SJ, Hannah RL, Chan MC, Nurnberg ST, Ouwehand WH, Bonzanni N, de Bruijn MF, Gottgens B. Elife. 2016 Feb 22;5:e11469. doi: 10.7554/eLife.11469. PubMed
H3(K27M/I) mutations promote context-dependent transformation in acute myeloid leukemia with RUNX1 alterations. Lehnertz B, Zhang YW, Boivin I, Mayotte N, Tomellini E, Chagraoui J, Lavallee VP, Hebert J, Sauvageau G. Blood. 2017 Nov 16;130(20):2204-2214. doi: 10.1182/blood-2017-03-774653. Epub 2017 Aug 30. PubMed
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis. Greenblatt SM, Man N, Hamard PJ, Asai T, Karl D, Martinez C, Bilbao D, Stathias V, Jermakowicz AM, Duffort S, Tadi M, Blumenthal E, Newman S, Vu L, Xu Y, Liu F, Schurer SC, McCabe MT, Kruger RG, Xu M, Yang FC, Tenen DG, Watts J, Vega F, Nimer SD. Cancer Cell. 2018 Jun 11;33(6):1111-1127.e5. doi: 10.1016/j.ccell.2018.05.007. PubMed
Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia. Gu Z, Liu Y, Zhang Y, Cao H, Lyu J, Wang X, Wylie A, Newkirk SJ, Jones AE, Lee M Jr, Botten GA, Deng M, Dickerson KE, Zhang CC, An W, Abrams JM, Xu J. Nat Genet. 2021 May;53(5):672-682. doi: 10.1038/s41588-021-00829-8. Epub 2021 Apr 8. PubMed
Non-conditioned bone marrow chimeric mouse generation using culture-based enrichment of hematopoietic stem and progenitor cells. Ochi K, Morita M, Wilkinson AC, Iwama A, Yamazaki S. Nat Commun. 2021 Jun 11;12(1):3568. doi: 10.1038/s41467-021-23763-z. PubMed
KDM4B promotes acute myeloid leukemia associated with AML1-ETO by regulating chromatin accessibility. Ueda T, Kanai A, Komuro A, Amano H, Ota K, Honda M, Kawazu M, Okada H. FASEB Bioadv. 2021 Sep 12;3(12):1020-1033. doi: 10.1096/fba.2021-00030. eCollection 2021 Dec. PubMed
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias. Golovine K, Abalakov G, Lian Z, Chatla S, Karami A, Chitrala KN, Madzo J, Nieborowska-Skorska M, Huang J, Skorski T. Blood Cancer J. 2023 Mar 23;13(1):42. doi: 10.1038/s41408-023-00810-0. PubMed
SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis. Yu PC, Hou D, Chang B, Liu N, Xu CH, Chen X, Hu CL, Liu T, Wang X, Zhang Q, Liu P, Jiang Y, Fei MY, Zong LJ, Zhang JY, Liu H, Chen BY, Chen SB, Wang Y, Li ZJ, Li X, Deng CH, Ren YY, Zhao M, Jiang S, Wang R, Jin J, Yang S, Xue K, Shi J, Chang CK, Shen S, Wang Z, He PC, Chen Z, Chen SJ, Sun XJ, Wang L. Dev Cell. 2024 May 17:S1534-5807(24)00296-X. doi: 10.1016/j.devcel.2024.04.023. PubMed

If you have published an article using this material, please email us at to have your article added to this page.